Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other nicotine-containing products, smoke-free products, and related electronic devices and accessories. The company offers IQOS smoke-free products, including heated tobacco and nicotine-containing vapor products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, and Parliament HeatSticks brands, as well as under the Fiit and Miix licensed brands. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. It markets and sells its products in the European Union, Eastern Europe, the Middle East, Africa, South and Southeast Asia, East Asia, Australia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
IPO Year:
Exchange: NYSE
Website: pmi.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/5/2024 | Buy → Hold | Argus | |
| 2/13/2024 | Sell → Hold | Societe Generale | |
| 1/23/2024 | $105.00 → $86.50 | Buy → Sell | UBS |
| 11/16/2023 | $95.00 | Neutral | Redburn Atlantic |
| 6/20/2023 | $109.00 → $117.00 | Neutral → Buy | Citigroup |
| 4/14/2023 | $114.00 | Buy | Stifel |
| 3/30/2023 | $109.00 → $116.00 | Neutral → Overweight | JP Morgan |
| 3/1/2023 | $106.00 → $116.00 | Neutral → Buy | UBS |
| 1/25/2023 | $95.00 → $120.00 | Neutral → Buy | Goldman |
| 1/23/2023 | $90.00 | Sell | Societe Generale |
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
Philip Morris International affiliate, Swedish Match, earned first-ever FDA authorization for a modified risk marketing claim and now is the first to achieve an FDA renewal PMI affiliates have secured 13 of the 16 modified risk tobacco product (MRTP) authorizations that the FDA has granted, demonstrating the company's commitment to a smoke-free future. The U.S. Food and Drug Administration (FDA) authorized a renewal of a risk modification order submitted by Swedish Match USA, Inc. (Swedish Match), an affiliate of Philip Morris International, Inc. (PMI) (NYSE:PM), for eight General snus products. As part of the authorization, the agency granted use of the modified risk claim to reach
Third-Quarter Reported Diluted EPS grew 49.2% to $1.97, Adjusted Diluted EPS increased by 14.4% to $1.91 and grew by 18.0% excluding currency Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2024 third-quarter and first nine-months results.1 "In the third quarter, we delivered exceptionally strong performance, with record quarterly net revenues and earnings per share," said Jacek Olczak, Chief Executive Officer. "This reflects excellent momentum across all regions and categories, with a reacceleration in IQOS adjusted in-market sales growth, strong ZYN volumes, and resilient combustible performance." "As a result of our strong year-to-date delivery, we
CCAA Plan Includes PMI's Canadian Affiliate RBH, Deconsolidated Since 2019; If RBH Reconsolidated, Expected to be Incremental to Key PMI Financial Metrics Regulatory News: Philip Morris International Inc. (PMI) has been informed by its deconsolidated Canadian affiliate, Rothmans, Benson & Hedges Inc. (RBH), that the court-appointed mediator and monitor in RBH's Companies' Creditors Arrangement Act (CCAA) proceeding filed a proposed plan of compromise and arrangement (Proposed Plan) outlining certain terms of a comprehensive resolution of tobacco product-related claims and litigation in Canada against RBH and its affiliates. The court-appointed mediator and monitors also filed substantiall
Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) will host a live audio webcast at www.pmi.com/2024Q3earnings on Tuesday, October 22, 2024, at 9:00 a.m. ET, to discuss its 2024 third-quarter and first nine-months results, which will be issued at approximately 7:00 a.m. ET the same day. The webcast will be hosted by Emmanuel Babeau, Chief Financial Officer, and will include discussion of PMI's financial results and a Q&A session with the investment community. The webcast will be in a listen-only mode. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at www.pmi.com/irapp. The webcast recording and the slides and script will be
Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services of Vectura and Phillips Medisize Phillips Medisize to add a market-leading position in inhalation combination product development to its existing suite of drug delivery device design capabilities Vectura employees to join a large global company, dedicated to improving patients' lives through innovative products and world class quality and manufacturing capabilities Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex
Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE:PM), today announces the sale of its subsidiary Vectura Group Ltd. (Vectura) to Molex Asia Holdings Ltd., and the establishment of master service agreements to develop Vectura Fertin Pharma's inhaled therapeutics proprietary pipeline. Vectura will be operated by Phillips Medisize, a Molex company. The sale includes upfront cash consideration of GBP 150 million, subject to customary purchase price adjustments, and potential deferred payments of up to GBP 148 million. The transaction is subject to customary closing conditions, including regulatory approval. "In line with our ambitions, Vectura has enabl
Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) has increased the company's regular quarterly dividend by 3.8% to an annualized rate of $5.40 per share. The new quarterly dividend of $1.35 per share, up from $1.30 per share, is payable on October 10, 2024, to shareholders of record as of September 26, 2024. The ex-dividend date is September 26, 2024. For additional dividend information, see www.pmi.com/dividend. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include produc
More than 35 billion illicit cigarettes were consumed across the 27 EU member states in 2023, close to 2022 figures. France continues to be the largest illicit market in the EU, and now accounts for 47.7% of total illicit cigarette consumption in the region. Illicit consumption has grown for the fifth consecutive year in Europe, reaching 52.2 billion cigarettes across the 38 countries included in this study. Nearly one in 10 cigarettes in the continent are illicit. More than 110 clandestine cigarette factories were dismantled in 2023, as illegal manufacturing sites are being set up nearer large end markets. Philip Morris International Inc. (PMI) (NYSE:PM) today warns about the high
Reaffirms 2024 Full-Year Forecast for Reported Diluted EPS of $5.89 to $6.01 and Adjusted Diluted EPS of $6.33 to $6.45, Representing Currency-Neutral Growth of 11% to 13% Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) Chief Executive Officer, Jacek Olczak, will today participate in a fireside chat session at the 2024 Barclays Global Consumer Staples Conference. The event will be webcast live in listen-only mode, beginning at approximately 12:45 p.m. ET, at www.pmi.com/2024barclays and on the PMI Investor Relations Mobile Application (www.pmi.com/irapp). An archived copy of the webcast will be available until Friday, October 4, 2024. 2024 Full-Year Forecast PMI
Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) will host a live webcast of a fireside chat session with Jacek Olczak, Chief Executive Officer, at the 2024 Barclays Global Consumer Staples Conference at www.pmi.com/2024barclays on Tuesday, September 3, 2024, at approximately 12:45 p.m. ET. An archived copy of the webcast will be available until 5:00 p.m. ET on Friday, October 4, 2024, at the same site. The webcast will provide a live stream of the entire PMI session. The webcast may also be accessed on mobile devices by downloading PMI's free Investor Relations Mobile App at www.pmi.com/irapp. Philip Morris International: Delivering a Smoke-Free Future Philip Morri
8-K - Philip Morris International Inc. (0001413329) (Filer)
25-NSE - Philip Morris International Inc. (0001413329) (Subject)
25-NSE - Philip Morris International Inc. (0001413329) (Subject)
8-K - Philip Morris International Inc. (0001413329) (Filer)
FWP - Philip Morris International Inc. (0001413329) (Subject)
10-Q - Philip Morris International Inc. (0001413329) (Filer)
144 - Philip Morris International Inc. (0001413329) (Subject)
8-K - Philip Morris International Inc. (0001413329) (Filer)
8-K - Philip Morris International Inc. (0001413329) (Filer)
8-K - Philip Morris International Inc. (0001413329) (Filer)
Third-Quarter Reported Diluted EPS grew 49.2% to $1.97, Adjusted Diluted EPS increased by 14.4% to $1.91 and grew by 18.0% excluding currency Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2024 third-quarter and first nine-months results.1 "In the third quarter, we delivered exceptionally strong performance, with record quarterly net revenues and earnings per share," said Jacek Olczak, Chief Executive Officer. "This reflects excellent momentum across all regions and categories, with a reacceleration in IQOS adjusted in-market sales growth, strong ZYN volumes, and resilient combustible performance." "As a result of our strong year-to-date delivery, we
CCAA Plan Includes PMI's Canadian Affiliate RBH, Deconsolidated Since 2019; If RBH Reconsolidated, Expected to be Incremental to Key PMI Financial Metrics Regulatory News: Philip Morris International Inc. (PMI) has been informed by its deconsolidated Canadian affiliate, Rothmans, Benson & Hedges Inc. (RBH), that the court-appointed mediator and monitor in RBH's Companies' Creditors Arrangement Act (CCAA) proceeding filed a proposed plan of compromise and arrangement (Proposed Plan) outlining certain terms of a comprehensive resolution of tobacco product-related claims and litigation in Canada against RBH and its affiliates. The court-appointed mediator and monitors also filed substantiall
Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE:PM), today announces the sale of its subsidiary Vectura Group Ltd. (Vectura) to Molex Asia Holdings Ltd., and the establishment of master service agreements to develop Vectura Fertin Pharma's inhaled therapeutics proprietary pipeline. Vectura will be operated by Phillips Medisize, a Molex company. The sale includes upfront cash consideration of GBP 150 million, subject to customary purchase price adjustments, and potential deferred payments of up to GBP 148 million. The transaction is subject to customary closing conditions, including regulatory approval. "In line with our ambitions, Vectura has enabl
Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) has increased the company's regular quarterly dividend by 3.8% to an annualized rate of $5.40 per share. The new quarterly dividend of $1.35 per share, up from $1.30 per share, is payable on October 10, 2024, to shareholders of record as of September 26, 2024. The ex-dividend date is September 26, 2024. For additional dividend information, see www.pmi.com/dividend. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include produc
Second-Quarter Reported Diluted EPS grew 52.5% to $1.54 Adjusted Diluted EPS decreased by 0.6% to $1.59; and grew by 10.6% excluding currency Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2024 second-quarter and first-half results.1 "The excellent momentum of our smoke-free business continued with an outstanding second-quarter and first-half performance," said Jacek Olczak, Chief Executive Officer. "The powerful combination of excellent underlying performance and proactive measures across all categories enabled our business to outperform once again, and we are on track for a strong 2024. As a result, we are raising our full-year guidance, desp
Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.30 per common share, payable on July 8, 2024, to shareholders of record as of June 21, 2024. The ex-dividend date is June 21, 2024. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily co
Reported Diluted EPS Grew 7.8% to $1.38 Adjusted Diluted EPS Grew 8.7% to $1.50; and by 23.2% excluding currency Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2024 first-quarter results1. "The strength of our first-quarter results with excellent top-line growth and significant margin expansion gives us the confidence to raise our 2024 currency-neutral guidance," said Jacek Olczak, Chief Executive Officer. "Strong smoke-free momentum continues with rapid underlying volume progression and accelerating organic net revenue and gross profit growth, fueled by the operating leverage of IQOS and the best-in-class economics of ZYN." "We are executing
Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.30 per common share, payable on April 9, 2024, to shareholders of record as of March 21, 2024. The ex-dividend date is March 20, 2024. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily
Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2023 fourth-quarter and full-year results. Further explanation of PMI's use of non-GAAP measures cited in this document and reconciliations to the most directly comparable U.S. GAAP measures can be found in the "Non-GAAP Measures, Glossary and Explanatory Notes" section of this release, in Exhibit 99.2 to the company's Form 8-K dated February 8, 2024, and at www.pmi.com/2023Q4earnings. 2023 FOURTH-QUARTER AND FULL-YEAR HIGHLIGHTS Fourth-Quarter Full-Year Change vs. Q4 2022 Change vs. FY 2022
Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.30 per common share, payable on January 10, 2024, to shareholders of record as of December 21, 2023. The ex-dividend date is December 20, 2023. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primar
JP Morgan analyst Jared Dinges maintains Philip Morris Intl (NYSE:PM) with a Overweight and raises the price target from $110 to $125.
Investors with a lot of money to spend have taken a bearish stance on Philip Morris Intl (NYSE:PM). And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PM, it often means somebody knows something is about to happen. So how do we know what these investors just did? Today, Benzinga's options scanner spotted 9 uncommon options trades for Philip Morris Intl. This isn't normal. The overall sentiment of these big-money traders is split between 22% bullish and 44%, bearish. Out of all of
B of A Securities analyst Lisa Lewandowski maintains Philip Morris Intl (NYSE:PM) with a Buy and raises the price target from $110 to $118.
Stifel analyst Matthew Smith maintains Philip Morris Intl (NYSE:PM) with a Buy and raises the price target from $115 to $120.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector. Kellanova (NYSE:K) Dividend Yield: 3.96% B of A Securities analyst Bryan Spillane maintained a Neutral rating and cut the
On Tuesday, Wall Street saw a mixed session, with small-cap stocks outperforming large caps as investors anticipated key earnings reports from Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL) and Tesla Inc. (NASDAQ:TSLA), set to be released after the close. The Russell 2000 index, as replicated by the iShares Russell 2000 ETF (NYSE:IWM), climbed 0.8%, while the tech-heavy Nasdaq 100 dipped 0.2%. This marked the ninth time in the last 10 sessions that small caps have outperformed tech stocks. The S&P 500 and the Dow Jones showed little movement. United Parcel Service Inc. (NYSE:UPS) stood out among the mega-cap stocks, plunging 14% after missing earnings and revenue estimates for the previous
Philip Morris International Inc. (NYSE:PM) shares are trading higher after the company reported better-than-expected second-quarter FY24 earnings and raised the adjusted EPS outlook. The company reported second-quarter growth of 5.6% year-on-year to $9.468 billion, beating the analyst consensus estimate of $9.183 billion. The smoke-free business accounted for 38.1% of the company’s total net revenues, up by 2.7pp versus second-quarter last year. Cigarette and Heated Tobacco unit (HTU) shipment volume in second-quarter grew by 2.5% Y/Y, reflecting growth of 13.1% and 0.4% for HTUs and cigarettes respectively. Adjusted EPS of $1.59 beat the consensus estimate of $1.57. Adjusted
The market mood turned jittery after Monday’s rebound, with index futures trading on either side of the unchanged line early Tuesday. The apprehensions reflect uncertainties regarding geopolitics, monetary policy, and the health of the reporting season ahead of earnings from AI stalwart Alphabet, Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) and electric-vehicle giant Tesla, Inc. (NASDAQ:TSLA). The Google-parent’s earnings could be seen as a foretaste of what is to come from the rest of the AI-levered stocks. Earnings news has been mixed. The tidings on the economic front are scarce, with only a housing market report due for the day. That said, traders may choose to remain cautious ahead of some key
Full-Year 2024 Forecast 2023 Growth Reported Diluted EPS $5.89 - $6.01 $ 5.02 Adjustments: Asset impairment and exit costs 0.09 0.06
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
SC 13G - Philip Morris International Inc. (0001413329) (Subject)
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
SC 13G - Philip Morris International Inc. (0001413329) (Subject)
Argus downgraded Philip Morris International from Buy to Hold
Societe Generale upgraded Philip Morris International from Sell to Hold
UBS downgraded Philip Morris International from Buy to Sell and set a new price target of $86.50 from $105.00 previously
Redburn Atlantic initiated coverage of Philip Morris International with a rating of Neutral and set a new price target of $95.00
Citigroup upgraded Philip Morris International from Neutral to Buy and set a new price target of $117.00 from $109.00 previously
Stifel resumed coverage of Philip Morris International with a rating of Buy and set a new price target of $114.00
JP Morgan upgraded Philip Morris International from Neutral to Overweight and set a new price target of $116.00 from $109.00 previously
UBS upgraded Philip Morris International from Neutral to Buy and set a new price target of $116.00 from $106.00 previously
Goldman upgraded Philip Morris International from Neutral to Buy and set a new price target of $120.00 from $95.00 previously
Societe Generale resumed coverage of Philip Morris International with a rating of Sell and set a new price target of $90.00
Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services of Vectura and Phillips Medisize Phillips Medisize to add a market-leading position in inhalation combination product development to its existing suite of drug delivery device design capabilities Vectura employees to join a large global company, dedicated to improving patients' lives through innovative products and world class quality and manufacturing capabilities Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex
Philip Morris International Inc. (PMI) (NYSE:PM) is pleased to announce the appointment of Christos Harpantidis to the position of Senior Vice President, External Affairs effective May 1, 2024. In his new role, Mr. Harpantidis will report to the company's CEO, Jacek Olczak. "Christos is an experienced business leader with a proven track record of engaging society on the benefits of tobacco harm reduction and risk-proportionate regulation for smoke-free products," said CEO Jacek Olczak. "He has been instrumental in building our smoke-free business in Greece and the South East Europe Area as we evolve away from cigarettes. I'm looking forward to working with Christos and excited to see what
In honor of Women's History Month and in advance of International Women's Day, investment and partnership support female economic empowerment and equality through entrepreneurship Today, Philip Morris International (PMI) (NYSE:PM) announces the launch of an extended partnership via its U.S. business to support female empowerment with a record-setting $5 million investment in the Women's Business Development Council (WBDC), a 501(c)(3) charitable organization dedicated to providing tools and resources to help women entrepreneurs thrive in business throughout Connecticut. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202403048002
GRANT-VALKARIA, Fla., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) ("Kaival Brands," the "Company," or "we") today announced that it has expanded the role of Barry M. Hopkins, Executive Chairman, to include the positions of Interim Chief Executive Officer & President. Former Chief Executive Officer & President, Eric Mosser, has been appointed Chief Executive Officer & President of Kaival Brands International, the Company's subsidiary which has an international licensing relationship with Philip Morris Products S.A., a wholly owned affiliate of Philip Morris International Inc. (NYSE:PM). Niraj Patel, Founder & Chief Science Officer of Kaival Brands
Philip Morris International Inc. (PMI) (NYSE:PM) announced today that on September 13, 2023, its Board of Directors appointed a new member, Ms. Victoria Harker, to serve on the Board of Directors, effective January 1, 2024. Victoria Harker is an experienced U.S. public-company Chief Financial Officer, having served in the role with three different companies, and she has been involved in significant corporate transformations in the consumer, industrial and utility sectors for over 25 years. She is a high-energy, action-oriented, strategic executive, who has worked at a significant scale, most recently as Executive Vice President and Chief Financial Officer of TEGNA Inc., a global media and
Dr. Badrul Chowdhury Appointed Chief Life Sciences Officer Dr. Matthew Holman Appointed Vice President, U.S. Scientific Engagement and Regulatory Strategy Philip Morris International Inc. (PMI) (NYSE:PM) announced today that it has appointed two former United States Food and Drug Administration (U.S. FDA) officials to key positions to accelerate its science-based transformation. Dr. Badrul Chowdhury is appointed PMI's Chief Life Sciences Officer, Smoke-Free Products, succeeding Jorge Insuasty, who will complete his move into the recently created position of President, Vectura Fertin Pharma. After a short transition period, Badrul will join PMI's Senior Management Team in January 2023,
Former Neustar President & CEO brings decades of leadership experience to Zayo board Zayo Group Holdings, Inc., a leading global communications infrastructure platform, today announced the appointment of Lisa Hook to its board of directors. Hook is a seasoned public company CEO, with extensive experience in cloud infrastructure, internet security, telecommunications, data analytics and digital marketing. "Lisa is a recognized leader with experience across multiple industries in the public and private sector," said Steve Smith, CEO of Zayo Group. "She will be an invaluable asset to our board as we continue to lead Zayo into its next phase of growth and service to our customers." Hook most
Philip Morris International Inc. (PMI) (NYSE:PM) today announced that on December 6, 2021, its Board of Directors appointed a new member, Ms. Dessislava ("Dessi") Temperley. Dessi Temperley is a former global public company CFO with more than 25 years of experience across a variety of sectors, working for several blue-chip multinationals. She has a proven track record of delivering strategic change with strong operational leadership resulting in superior financial results, most recently as Group CFO and Executive Board Member of Beiersdorf AG. Prior to this, she held several senior positions at Nestlé. She is also a non-executive member of the Board of Directors for Coca-Cola Europacific P
VANCOUVER, BC, Oct. 18, 2021 /PRNewswire/ - Ritchie Bros. Auctioneers Incorporated (NYSE:RBA) (TSX:RBA) ("Ritchie Bros. and the "Company"), is pleased to announce the appointment of Lisa Hook to its Board of Directors, effective November 1, 2021 "We are pleased to welcome Lisa as our newest director. Her vast and diverse experience of transforming and scaling businesses with technology adds a valuable perspective to our Board" said Erik Olsson, Chairman of the Board for Ritchie Bros. Commenting on the appointment, Ann Fandozzi, CEO of Ritchie Bros., said: "I am excited by Lisa joining the board and helping Ritchie Bros achieve our strategic vision to be the trusted global marketplace for in
Jacek Olczak, Chief Executive Officer of Philip Morris International (PMI) (NYSE:PM), today announced a new structure for the Americas with the appointment of Deepak Mishra—formerly Chief Strategy Officer—as President, Americas Region, covering the United States, Canada, and Latin America. The appointment is effective July 1. The new structure in the Americas will focus on three areas: strengthening PMI's leadership in Latin America & Canada as the company accelerates toward a smoke-free future; deepening efforts with partners to commercialize reduced risk products in the U.S.; and building a vital launchpad for the company's "beyond nicotine" strategy in the U.S., in coordination with PMI